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OBJECTIVE 
To compare tumour volumes created using F 18 FDG PET CT scan before 
starting treatment and after completion of chemo radiation/radical radiotherapy 
to assess treatment response using PERCIST criteria in Head and Neck cancers 
and to create a prognostication algorithm to predict treatment response.  
METHODS 
This was a prospective cross-sectional study done in the Department of 
Radiation Oncology at Christian Medical College, Vellore. Patients with 
squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and 
laryngopharynx planned for radical irradiation with or without concurrent 
systemic treatment were recruited and underwent a PET CT scan in planning 
position. These patients underwent a response assessment PET CT 12 weeks 
following treatment. Baseline diagnostic and staging advantage of PET CT, its 
role in RT planning, PET CT biomarkers were analysed. Response assessment 
was done by clinical examination and NPL scopy, RECIST and PERCIST and 
response assessment was analysed.  
RESULTS 
PET CT was beneficial in diagnosis, staging and detection of metastatic 
disease. It was useful in delineation of tumor volume and reduction in volumes. 
Baseline TLG was a good predictive biomarker with a low baseline value 
suggestive of good response to treatment. PERCIST calculated using change in 
SUL had good correlation with response. The patients who had complete 
metabolic response had a high negative predictive value suggestive of absence 
of disease. PET CT helped to differentiate abnormal scopy findings from 
diseased scopy by assessing decline in SUL value. PERCIST PMR patients 
with a normal scopy and complete response in RECIST had a significant drop 
in SUL, TLG and SUVmax compared to stable and progressive metabolic 
response. Change in TLG was a good marker to prognosticate response to 
treatment. Change in MTV was a prior biomarker to assess response. 
CONCLUSION 
PET CT was of use in diagnosis, staging, RT planning and response 
assessment. Baseline TLG was the best biomarker to prognosticate response to 
treatment. PERCIST SUL was the best way to assess response. 
	
